Stay updated on PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC
Sign up to get notified when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.

Latest updates to the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe record history now includes a new revision entry, v3.6.5. The previous revision, v3.6.4, is removed from the visible history, indicating an administrative update to the record version rather than substantive trial changes.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new revision entry v3.6.4 was added to the Record History. The prior v3.6.3 entry was removed.SummaryDifference0.1%

- Check47 days agoChange DetectedA new revision entry, v3.6.3, was added to the study's record history. The previous revision, v3.6.2, was removed from the current history view.SummaryDifference0.1%

- Check54 days agoChange DetectedThe Record History shows a new Revision: v3.6.2 entry replacing v3.6.0, representing a new software release for the study record interface.SummaryDifference0.1%

- Check68 days agoChange DetectedThe Version History UI now displays 'Last verified' and 'Last known status was' and adds a 'Revision: v3.6.0' tag, replacing the previous 'Verified', 'Last known status was:', and 'Revision: v3.5.5' indicators. This change updates how revision metadata is presented without modifying the underlying study data.SummaryDifference2%

- Check75 days agoChange DetectedA new software revision entry (v3.5.5) was added to the Record History. The previous revision (v3.5.4) was removed, reflecting a minor platform update.SummaryDifference0.1%

Stay in the know with updates to PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC
Enter your email address, and we'll notify you when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.